De santis, Maria
 Distribuzione geografica
Continente #
NA - Nord America 5.127
AS - Asia 3.563
EU - Europa 1.279
AF - Africa 726
SA - Sud America 703
OC - Oceania 7
Totale 11.405
Nazione #
US - Stati Uniti d'America 5.000
SG - Singapore 2.127
CN - Cina 655
SC - Seychelles 611
BR - Brasile 578
VN - Vietnam 331
IT - Italia 254
FI - Finlandia 226
IE - Irlanda 157
DE - Germania 132
HK - Hong Kong 100
FR - Francia 98
IN - India 92
GB - Regno Unito 86
NL - Olanda 64
CA - Canada 62
AR - Argentina 51
NG - Nigeria 45
MX - Messico 43
RU - Federazione Russa 38
SE - Svezia 37
BD - Bangladesh 34
PL - Polonia 32
ZA - Sudafrica 29
IQ - Iraq 25
CZ - Repubblica Ceca 21
EC - Ecuador 21
TR - Turchia 21
ID - Indonesia 20
MK - Macedonia 20
JP - Giappone 18
CO - Colombia 17
ES - Italia 17
BE - Belgio 15
PK - Pakistan 15
PH - Filippine 14
SA - Arabia Saudita 13
UA - Ucraina 12
UZ - Uzbekistan 12
CL - Cile 11
IL - Israele 11
AT - Austria 10
JO - Giordania 9
IR - Iran 8
LT - Lituania 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
NP - Nepal 7
TN - Tunisia 7
AU - Australia 6
EG - Egitto 6
KR - Corea 6
MA - Marocco 6
MY - Malesia 6
AL - Albania 5
AM - Armenia 5
DZ - Algeria 5
LB - Libano 5
PE - Perù 5
PY - Paraguay 5
BG - Bulgaria 4
JM - Giamaica 4
KE - Kenya 4
KG - Kirghizistan 4
PT - Portogallo 4
UY - Uruguay 4
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
DK - Danimarca 3
HN - Honduras 3
HR - Croazia 3
KZ - Kazakistan 3
NO - Norvegia 3
PA - Panama 3
RO - Romania 3
RS - Serbia 3
SN - Senegal 3
AO - Angola 2
BO - Bolivia 2
BW - Botswana 2
CR - Costa Rica 2
DM - Dominica 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
NI - Nicaragua 2
QA - Qatar 2
TT - Trinidad e Tobago 2
UG - Uganda 2
BB - Barbados 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
GY - Guiana 1
Totale 11.389
Città #
Singapore 895
Chandler 665
Ashburn 585
San Jose 544
Dallas 519
The Dalles 329
Shanghai 257
Helsinki 225
Boardman 188
New York 188
Wilmington 175
Dublin 157
Los Angeles 143
Beijing 130
Ho Chi Minh City 106
Hong Kong 88
Hanoi 83
San Mateo 77
Santa Clara 74
Paris 60
São Paulo 50
Milan 48
Amsterdam 47
Ann Arbor 46
Sassari 45
Benin City 41
London 38
Lawrence 35
Princeton 35
Buffalo 34
Assago 32
Council Bluffs 32
Leawood 31
Pune 29
Falkenstein 28
Naples 28
Warsaw 25
Chennai 23
Phoenix 21
Woodbridge 21
Columbus 19
Toronto 19
Da Nang 18
Orem 18
Brno 17
Mexico City 17
Munich 17
Seattle 17
Belo Horizonte 16
Boston 16
Frankfurt am Main 16
Montreal 16
Brussels 15
Charlotte 15
Haiphong 15
San Francisco 14
Fairfield 13
Stockholm 13
Brooklyn 12
Curitiba 12
Rio de Janeiro 12
Tokyo 12
Chicago 11
Johannesburg 11
Tashkent 11
Brasília 10
Houston 10
San Diego 10
Buenos Aires 9
Dhaka 9
Moscow 9
Porto Alegre 9
Skopje 9
Pasadena 8
Quito 8
Rome 8
Amman 7
Bogotá 7
Goiânia 7
Guayaquil 7
Istanbul 7
Mumbai 7
Atlanta 6
Aurora 6
Baghdad 6
Denver 6
Jeddah 6
Kocaeli 6
Manchester 6
Miami 6
Bitola 5
Biên Hòa 5
Campo Grande 5
Cape Town 5
Guangzhou 5
Hangzhou 5
Jakarta 5
Jundiaí 5
Manaus 5
New Delhi 5
Totale 6.788
Nome #
Serum anti-phospholipid antibody prevalence and cardiovascular significance in the general population of the camelia study 698
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 211
Acute phase reactions after zoledronic acid infusion: protective role of 25-OH vitamin D and previous oral bisphosphonate therapy 144
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 132
Personalized medicine in rheumatology : the paradigm of serum autoantibodies 129
Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population 123
Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement 118
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 118
DNA Methylation Signature in Monozygotic Twins Discordant for Psoriatic Disease 117
X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma 116
Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years 110
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 109
Additional organs involved in antiphospholipid syndrome : eye, ear-nose-throat, lung, gastroenteric system, endocrine glands 109
Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review 108
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years 107
Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies 101
Gamma-delta T lymphocytes and 25-hydroxy vitamin D levels as key factors in autoimmunity and inflammation : the case of zoledronic acid-induced acute phase reaction 101
5 reasons to encourage anti-SARS-CoV-2 vaccination in patients with rheumatic diseases 100
Liver involvement in subjects with rheumatic disease 97
Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue Disease 95
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 94
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis 90
Established and novel insights to guide cancer assessment in patients with idiopathic inflammatory myopathies 88
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 88
Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis 87
Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study' 87
Effects of type II collagen epitope carbamylation and citrullination in HLA-DR4+ monozygotic twins discordant for rheumatoid arthritis 87
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19 87
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19 87
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 86
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 85
The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis : a Critical Review 84
Infectious agents and xenobiotics in the etiology of primary biliary cirrhosis 83
Nailfold videocapillaroscopy and serum VEGF levels in scleroderma are associated with internal organ involvement 83
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 82
Liver abnormalities in connective tissue diseases 80
Autoantibodies and organ involvement in systemic sclerosis 77
Analysis of interstitial lung involvement in a cohort of 100 patients with systemic sclerosis. Prevalence of alveolitis detected by bronchoalveolar lavage and HRCT 77
T-Cell response to carbamylated and citrullinated collagen epitopes in patients with rheumatoid arthritis carrying DRβ1*04 77
Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis. 77
The role of Wnt pathway in the pathogenesis of OA and its potential therapeutic implications in the field of regenerative medicine 77
Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care Professionals 76
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 76
Humoral Response Against LL-37 in Psoriatic Disease: Comment on the Article by Yuan et al 75
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 74
Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre study 73
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 72
Artriti infettive 71
B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial 70
B cell depletion and a T cell-targeted therapy allows to control the sudden onset of diabetes and lupus, without steroids 70
Detection of anti-mitochondrial antibodies by immunoprecipitation in patients with systemic sclerosis 70
Type III interferons disrupt the lung epithelial barrier upon viral recognition 69
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis 69
Viral Respiratory Pathogens and Lung Injury 69
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy 69
Comment on: Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement 67
Gastrointestinal symptoms and nutritional profile during pregnancy 67
DRESS syndrome in response to Denosumab: First documented case report 66
The elegance of a macrophage 66
Digital ulcers predict a worse disease course in patients with systemic sclerosis 65
Psoriatic arthritis induced by anti-PD1 and treated with apremilast: a case report and review of the literature 64
Add-on rituximab for primary heart involvement associated with systemic sclerosis: A step forward in the tailored treatment of myocarditis? 64
Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis 63
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study 63
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients 63
Concomitant Pyoderma Gangrenosum-like and Amicrobial Pustulosis of the Folds: a Case Report 63
Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency 62
Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: A report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group 62
Cancer in connective tissue disease 62
BAFF and rheumatic autoimmune disorders: implications for disease management and therapy 62
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 62
La sclerodermia 61
The biology, pathogenetic role, clinical implications, and open issues of serum anti-neutrophil cytoplasmic antibodies 61
How advances in personalized medicine will change rheumatology 61
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis 61
The autoimmune landscape of Porto-sinusoidal vascular disorder: What the rheumatologist needs to know 60
Lupus anticoagulant and ischemic myocardial microangiopathy in rheumatoid arthritis 60
Approaches for the diagnosis and treatment of VEXAS syndrome: the importance of clinical suspicion and the use of methotrexate 60
Environmental triggers for connective tissue disease: the case of COVID-19 associated with dermatomyositis-specific autoantibodies 60
Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis 59
New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine 59
Tumori ossei 59
The therapeutic potential of epigenetics in autoimmune diseases 59
Pharmacogenetics/pharmacogenomics and antirheumatic drugs in rheumatology 58
The autoinflammatory side of systemic sclerosis 58
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases 57
The genetic bases of asthma 57
Obesity and fibromyalgia are associated with Difficult-to-Treat Rheumatoid Arthritis (D2T-RA) independent of age and gender 56
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature 56
Tumor necrosis factor-alpha inhibitor therapy in erosive polyarthritis secondary to systemic sclerosis 55
Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies 55
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrum 54
Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database 54
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 53
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 53
The geoepidemiology of autoimmune liver disease 53
Treatable Traits in Systemic Sclerosis 52
Septic sacroiliitis: an uncommon septic arthritis 52
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals 52
First Report of the Prevalence at Baseline and after 1-Year Follow-Up of Treatable Traits in Interstitial Lung Diseases 52
Totale 8.377
Categoria #
all - tutte 67.432
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.432


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 0 0 0 0 0 0 0 0 58
2021/2022191 12 2 3 42 1 0 9 29 10 17 42 24
2022/20231.630 102 102 152 222 118 150 5 193 289 143 129 25
2023/20241.281 105 102 272 106 35 175 82 33 21 42 80 228
2024/20252.539 47 19 621 42 58 252 159 140 321 450 233 197
2025/20265.534 779 281 617 474 224 252 1.388 264 282 324 356 293
Totale 11.538